Medical Care
Global CAR-T Cell Therapy Market Research Report 2025
- May 05, 25
- ID: 226391
- Pages: 78
- Figures: 81
- Views: 49
The global market for CAR-T Cell Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for CAR-T Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CAR-T Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of CAR-T Cell Therapy include Bristol Myers Squibb, Gilead Sciences, Novartis, Autolus, Janssen, JW Therapeutics, Beijing Immunochina Medical Science & Technology, Bioray Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CAR-T Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Cell Therapy.
The CAR-T Cell Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CAR-T Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-T Cell Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bristol Myers Squibb
Gilead Sciences
Novartis
Autolus
Janssen
JW Therapeutics
Beijing Immunochina Medical Science & Technology
Bioray Laboratories
Segment by Type
CD19
BCMA
CD19/CD22
Other
Segment by Application
Non-hodgkin Lymphoma
Multiple Myeloma
Acute Lymphoblastic Leukemia
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of CAR-T Cell Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of CAR-T Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
North American market for CAR-T Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CAR-T Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of CAR-T Cell Therapy include Bristol Myers Squibb, Gilead Sciences, Novartis, Autolus, Janssen, JW Therapeutics, Beijing Immunochina Medical Science & Technology, Bioray Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CAR-T Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Cell Therapy.
The CAR-T Cell Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CAR-T Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-T Cell Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bristol Myers Squibb
Gilead Sciences
Novartis
Autolus
Janssen
JW Therapeutics
Beijing Immunochina Medical Science & Technology
Bioray Laboratories
Segment by Type
CD19
BCMA
CD19/CD22
Other
Segment by Application
Non-hodgkin Lymphoma
Multiple Myeloma
Acute Lymphoblastic Leukemia
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of CAR-T Cell Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of CAR-T Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 CAR-T Cell Therapy Market Overview
1.1 Product Definition
1.2 CAR-T Cell Therapy by Type
1.2.1 Global CAR-T Cell Therapy Market Value Comparison by Type (2024 VS 2031)
1.2.2 CD19
1.2.3 BCMA
1.2.4 CD19/CD22
1.2.5 Other
1.3 CAR-T Cell Therapy by Application
1.3.1 Global CAR-T Cell Therapy Market Value by Application (2024 VS 2031)
1.3.2 Non-hodgkin Lymphoma
1.3.3 Multiple Myeloma
1.3.4 Acute Lymphoblastic Leukemia
1.3.5 Other
1.4 Global CAR-T Cell Therapy Market Size Estimates and Forecasts
1.4.1 Global CAR-T Cell Therapy Revenue 2020-2031
1.4.2 Global CAR-T Cell Therapy Sales 2020-2031
1.4.3 Global CAR-T Cell Therapy Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 CAR-T Cell Therapy Market Competition by Manufacturers
2.1 Global CAR-T Cell Therapy Sales Market Share by Manufacturers (2020-2025)
2.2 Global CAR-T Cell Therapy Revenue Market Share by Manufacturers (2020-2025)
2.3 Global CAR-T Cell Therapy Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of CAR-T Cell Therapy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of CAR-T Cell Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CAR-T Cell Therapy, Product Type & Application
2.7 Global Key Manufacturers of CAR-T Cell Therapy, Date of Enter into This Industry
2.8 Global CAR-T Cell Therapy Market Competitive Situation and Trends
2.8.1 Global CAR-T Cell Therapy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest CAR-T Cell Therapy Players Market Share by Revenue
2.8.3 Global CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global CAR-T Cell Therapy Market Scenario by Region
3.1 Global CAR-T Cell Therapy Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global CAR-T Cell Therapy Sales by Region: 2020-2031
3.2.1 Global CAR-T Cell Therapy Sales by Region: 2020-2025
3.2.2 Global CAR-T Cell Therapy Sales by Region: 2026-2031
3.3 Global CAR-T Cell Therapy Revenue by Region: 2020-2031
3.3.1 Global CAR-T Cell Therapy Revenue by Region: 2020-2025
3.3.2 Global CAR-T Cell Therapy Revenue by Region: 2026-2031
3.4 North America CAR-T Cell Therapy Market Facts & Figures by Country
3.4.1 North America CAR-T Cell Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America CAR-T Cell Therapy Sales by Country (2020-2031)
3.4.3 North America CAR-T Cell Therapy Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe CAR-T Cell Therapy Market Facts & Figures by Country
3.5.1 Europe CAR-T Cell Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe CAR-T Cell Therapy Sales by Country (2020-2031)
3.5.3 Europe CAR-T Cell Therapy Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CAR-T Cell Therapy Market Facts & Figures by Region
3.6.1 Asia Pacific CAR-T Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific CAR-T Cell Therapy Sales by Region (2020-2031)
3.6.3 Asia Pacific CAR-T Cell Therapy Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CAR-T Cell Therapy Market Facts & Figures by Country
3.7.1 Latin America CAR-T Cell Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America CAR-T Cell Therapy Sales by Country (2020-2031)
3.7.3 Latin America CAR-T Cell Therapy Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CAR-T Cell Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa CAR-T Cell Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa CAR-T Cell Therapy Sales by Country (2020-2031)
3.8.3 Middle East and Africa CAR-T Cell Therapy Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CAR-T Cell Therapy Sales by Type (2020-2031)
4.1.1 Global CAR-T Cell Therapy Sales by Type (2020-2025)
4.1.2 Global CAR-T Cell Therapy Sales by Type (2026-2031)
4.1.3 Global CAR-T Cell Therapy Sales Market Share by Type (2020-2031)
4.2 Global CAR-T Cell Therapy Revenue by Type (2020-2031)
4.2.1 Global CAR-T Cell Therapy Revenue by Type (2020-2025)
4.2.2 Global CAR-T Cell Therapy Revenue by Type (2026-2031)
4.2.3 Global CAR-T Cell Therapy Revenue Market Share by Type (2020-2031)
4.3 Global CAR-T Cell Therapy Price by Type (2020-2031)
5 Segment by Application
5.1 Global CAR-T Cell Therapy Sales by Application (2020-2031)
5.1.1 Global CAR-T Cell Therapy Sales by Application (2020-2025)
5.1.2 Global CAR-T Cell Therapy Sales by Application (2026-2031)
5.1.3 Global CAR-T Cell Therapy Sales Market Share by Application (2020-2031)
5.2 Global CAR-T Cell Therapy Revenue by Application (2020-2031)
5.2.1 Global CAR-T Cell Therapy Revenue by Application (2020-2025)
5.2.2 Global CAR-T Cell Therapy Revenue by Application (2026-2031)
5.2.3 Global CAR-T Cell Therapy Revenue Market Share by Application (2020-2031)
5.3 Global CAR-T Cell Therapy Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Company Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bristol Myers Squibb CAR-T Cell Therapy Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 Gilead Sciences
6.2.1 Gilead Sciences Company Information
6.2.2 Gilead Sciences Description and Business Overview
6.2.3 Gilead Sciences CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Gilead Sciences CAR-T Cell Therapy Product Portfolio
6.2.5 Gilead Sciences Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis CAR-T Cell Therapy Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Autolus
6.4.1 Autolus Company Information
6.4.2 Autolus Description and Business Overview
6.4.3 Autolus CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Autolus CAR-T Cell Therapy Product Portfolio
6.4.5 Autolus Recent Developments/Updates
6.5 Janssen
6.5.1 Janssen Company Information
6.5.2 Janssen Description and Business Overview
6.5.3 Janssen CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Janssen CAR-T Cell Therapy Product Portfolio
6.5.5 Janssen Recent Developments/Updates
6.6 JW Therapeutics
6.6.1 JW Therapeutics Company Information
6.6.2 JW Therapeutics Description and Business Overview
6.6.3 JW Therapeutics CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.6.4 JW Therapeutics CAR-T Cell Therapy Product Portfolio
6.6.5 JW Therapeutics Recent Developments/Updates
6.7 Beijing Immunochina Medical Science & Technology
6.7.1 Beijing Immunochina Medical Science & Technology Company Information
6.7.2 Beijing Immunochina Medical Science & Technology Description and Business Overview
6.7.3 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Product Portfolio
6.7.5 Beijing Immunochina Medical Science & Technology Recent Developments/Updates
6.8 Bioray Laboratories
6.8.1 Bioray Laboratories Company Information
6.8.2 Bioray Laboratories Description and Business Overview
6.8.3 Bioray Laboratories CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bioray Laboratories CAR-T Cell Therapy Product Portfolio
6.8.5 Bioray Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CAR-T Cell Therapy Industry Chain Analysis
7.2 CAR-T Cell Therapy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CAR-T Cell Therapy Production Mode & Process Analysis
7.4 CAR-T Cell Therapy Sales and Marketing
7.4.1 CAR-T Cell Therapy Sales Channels
7.4.2 CAR-T Cell Therapy Distributors
7.5 CAR-T Cell Therapy Customer Analysis
8 CAR-T Cell Therapy Market Dynamics
8.1 CAR-T Cell Therapy Industry Trends
8.2 CAR-T Cell Therapy Market Drivers
8.3 CAR-T Cell Therapy Market Challenges
8.4 CAR-T Cell Therapy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 CAR-T Cell Therapy by Type
1.2.1 Global CAR-T Cell Therapy Market Value Comparison by Type (2024 VS 2031)
1.2.2 CD19
1.2.3 BCMA
1.2.4 CD19/CD22
1.2.5 Other
1.3 CAR-T Cell Therapy by Application
1.3.1 Global CAR-T Cell Therapy Market Value by Application (2024 VS 2031)
1.3.2 Non-hodgkin Lymphoma
1.3.3 Multiple Myeloma
1.3.4 Acute Lymphoblastic Leukemia
1.3.5 Other
1.4 Global CAR-T Cell Therapy Market Size Estimates and Forecasts
1.4.1 Global CAR-T Cell Therapy Revenue 2020-2031
1.4.2 Global CAR-T Cell Therapy Sales 2020-2031
1.4.3 Global CAR-T Cell Therapy Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 CAR-T Cell Therapy Market Competition by Manufacturers
2.1 Global CAR-T Cell Therapy Sales Market Share by Manufacturers (2020-2025)
2.2 Global CAR-T Cell Therapy Revenue Market Share by Manufacturers (2020-2025)
2.3 Global CAR-T Cell Therapy Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of CAR-T Cell Therapy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of CAR-T Cell Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CAR-T Cell Therapy, Product Type & Application
2.7 Global Key Manufacturers of CAR-T Cell Therapy, Date of Enter into This Industry
2.8 Global CAR-T Cell Therapy Market Competitive Situation and Trends
2.8.1 Global CAR-T Cell Therapy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest CAR-T Cell Therapy Players Market Share by Revenue
2.8.3 Global CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global CAR-T Cell Therapy Market Scenario by Region
3.1 Global CAR-T Cell Therapy Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global CAR-T Cell Therapy Sales by Region: 2020-2031
3.2.1 Global CAR-T Cell Therapy Sales by Region: 2020-2025
3.2.2 Global CAR-T Cell Therapy Sales by Region: 2026-2031
3.3 Global CAR-T Cell Therapy Revenue by Region: 2020-2031
3.3.1 Global CAR-T Cell Therapy Revenue by Region: 2020-2025
3.3.2 Global CAR-T Cell Therapy Revenue by Region: 2026-2031
3.4 North America CAR-T Cell Therapy Market Facts & Figures by Country
3.4.1 North America CAR-T Cell Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America CAR-T Cell Therapy Sales by Country (2020-2031)
3.4.3 North America CAR-T Cell Therapy Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe CAR-T Cell Therapy Market Facts & Figures by Country
3.5.1 Europe CAR-T Cell Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe CAR-T Cell Therapy Sales by Country (2020-2031)
3.5.3 Europe CAR-T Cell Therapy Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CAR-T Cell Therapy Market Facts & Figures by Region
3.6.1 Asia Pacific CAR-T Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific CAR-T Cell Therapy Sales by Region (2020-2031)
3.6.3 Asia Pacific CAR-T Cell Therapy Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CAR-T Cell Therapy Market Facts & Figures by Country
3.7.1 Latin America CAR-T Cell Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America CAR-T Cell Therapy Sales by Country (2020-2031)
3.7.3 Latin America CAR-T Cell Therapy Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CAR-T Cell Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa CAR-T Cell Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa CAR-T Cell Therapy Sales by Country (2020-2031)
3.8.3 Middle East and Africa CAR-T Cell Therapy Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CAR-T Cell Therapy Sales by Type (2020-2031)
4.1.1 Global CAR-T Cell Therapy Sales by Type (2020-2025)
4.1.2 Global CAR-T Cell Therapy Sales by Type (2026-2031)
4.1.3 Global CAR-T Cell Therapy Sales Market Share by Type (2020-2031)
4.2 Global CAR-T Cell Therapy Revenue by Type (2020-2031)
4.2.1 Global CAR-T Cell Therapy Revenue by Type (2020-2025)
4.2.2 Global CAR-T Cell Therapy Revenue by Type (2026-2031)
4.2.3 Global CAR-T Cell Therapy Revenue Market Share by Type (2020-2031)
4.3 Global CAR-T Cell Therapy Price by Type (2020-2031)
5 Segment by Application
5.1 Global CAR-T Cell Therapy Sales by Application (2020-2031)
5.1.1 Global CAR-T Cell Therapy Sales by Application (2020-2025)
5.1.2 Global CAR-T Cell Therapy Sales by Application (2026-2031)
5.1.3 Global CAR-T Cell Therapy Sales Market Share by Application (2020-2031)
5.2 Global CAR-T Cell Therapy Revenue by Application (2020-2031)
5.2.1 Global CAR-T Cell Therapy Revenue by Application (2020-2025)
5.2.2 Global CAR-T Cell Therapy Revenue by Application (2026-2031)
5.2.3 Global CAR-T Cell Therapy Revenue Market Share by Application (2020-2031)
5.3 Global CAR-T Cell Therapy Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Company Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bristol Myers Squibb CAR-T Cell Therapy Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 Gilead Sciences
6.2.1 Gilead Sciences Company Information
6.2.2 Gilead Sciences Description and Business Overview
6.2.3 Gilead Sciences CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Gilead Sciences CAR-T Cell Therapy Product Portfolio
6.2.5 Gilead Sciences Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis CAR-T Cell Therapy Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Autolus
6.4.1 Autolus Company Information
6.4.2 Autolus Description and Business Overview
6.4.3 Autolus CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Autolus CAR-T Cell Therapy Product Portfolio
6.4.5 Autolus Recent Developments/Updates
6.5 Janssen
6.5.1 Janssen Company Information
6.5.2 Janssen Description and Business Overview
6.5.3 Janssen CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Janssen CAR-T Cell Therapy Product Portfolio
6.5.5 Janssen Recent Developments/Updates
6.6 JW Therapeutics
6.6.1 JW Therapeutics Company Information
6.6.2 JW Therapeutics Description and Business Overview
6.6.3 JW Therapeutics CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.6.4 JW Therapeutics CAR-T Cell Therapy Product Portfolio
6.6.5 JW Therapeutics Recent Developments/Updates
6.7 Beijing Immunochina Medical Science & Technology
6.7.1 Beijing Immunochina Medical Science & Technology Company Information
6.7.2 Beijing Immunochina Medical Science & Technology Description and Business Overview
6.7.3 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Product Portfolio
6.7.5 Beijing Immunochina Medical Science & Technology Recent Developments/Updates
6.8 Bioray Laboratories
6.8.1 Bioray Laboratories Company Information
6.8.2 Bioray Laboratories Description and Business Overview
6.8.3 Bioray Laboratories CAR-T Cell Therapy Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bioray Laboratories CAR-T Cell Therapy Product Portfolio
6.8.5 Bioray Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CAR-T Cell Therapy Industry Chain Analysis
7.2 CAR-T Cell Therapy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CAR-T Cell Therapy Production Mode & Process Analysis
7.4 CAR-T Cell Therapy Sales and Marketing
7.4.1 CAR-T Cell Therapy Sales Channels
7.4.2 CAR-T Cell Therapy Distributors
7.5 CAR-T Cell Therapy Customer Analysis
8 CAR-T Cell Therapy Market Dynamics
8.1 CAR-T Cell Therapy Industry Trends
8.2 CAR-T Cell Therapy Market Drivers
8.3 CAR-T Cell Therapy Market Challenges
8.4 CAR-T Cell Therapy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global CAR-T Cell Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global CAR-T Cell Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global CAR-T Cell Therapy Market Competitive Situation by Manufacturers in 2024
Table 4. Global CAR-T Cell Therapy Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global CAR-T Cell Therapy Sales Market Share by Manufacturers (2020-2025)
Table 6. Global CAR-T Cell Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global CAR-T Cell Therapy Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market CAR-T Cell Therapy Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of CAR-T Cell Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of CAR-T Cell Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CAR-T Cell Therapy, Product Type & Application
Table 12. Global Key Manufacturers of CAR-T Cell Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CAR-T Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Therapy as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CAR-T Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global CAR-T Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 18. Global CAR-T Cell Therapy Sales Market Share by Region (2020-2025)
Table 19. Global CAR-T Cell Therapy Sales by Region (2026-2031) & (K Units)
Table 20. Global CAR-T Cell Therapy Sales Market Share by Region (2026-2031)
Table 21. Global CAR-T Cell Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global CAR-T Cell Therapy Revenue Market Share by Region (2020-2025)
Table 23. Global CAR-T Cell Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global CAR-T Cell Therapy Revenue Market Share by Region (2026-2031)
Table 25. North America CAR-T Cell Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America CAR-T Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 27. North America CAR-T Cell Therapy Sales by Country (2026-2031) & (K Units)
Table 28. North America CAR-T Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America CAR-T Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe CAR-T Cell Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe CAR-T Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 32. Europe CAR-T Cell Therapy Sales by Country (2026-2031) & (K Units)
Table 33. Europe CAR-T Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe CAR-T Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific CAR-T Cell Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific CAR-T Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific CAR-T Cell Therapy Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific CAR-T Cell Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific CAR-T Cell Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America CAR-T Cell Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America CAR-T Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 42. Latin America CAR-T Cell Therapy Sales by Country (2026-2031) & (K Units)
Table 43. Latin America CAR-T Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America CAR-T Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa CAR-T Cell Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa CAR-T Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa CAR-T Cell Therapy Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa CAR-T Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa CAR-T Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global CAR-T Cell Therapy Sales (K Units) by Type (2020-2025)
Table 51. Global CAR-T Cell Therapy Sales (K Units) by Type (2026-2031)
Table 52. Global CAR-T Cell Therapy Sales Market Share by Type (2020-2025)
Table 53. Global CAR-T Cell Therapy Sales Market Share by Type (2026-2031)
Table 54. Global CAR-T Cell Therapy Revenue (US$ Million) by Type (2020-2025)
Table 55. Global CAR-T Cell Therapy Revenue (US$ Million) by Type (2026-2031)
Table 56. Global CAR-T Cell Therapy Revenue Market Share by Type (2020-2025)
Table 57. Global CAR-T Cell Therapy Revenue Market Share by Type (2026-2031)
Table 58. Global CAR-T Cell Therapy Price (US$/Unit) by Type (2020-2025)
Table 59. Global CAR-T Cell Therapy Price (US$/Unit) by Type (2026-2031)
Table 60. Global CAR-T Cell Therapy Sales (K Units) by Application (2020-2025)
Table 61. Global CAR-T Cell Therapy Sales (K Units) by Application (2026-2031)
Table 62. Global CAR-T Cell Therapy Sales Market Share by Application (2020-2025)
Table 63. Global CAR-T Cell Therapy Sales Market Share by Application (2026-2031)
Table 64. Global CAR-T Cell Therapy Revenue (US$ Million) by Application (2020-2025)
Table 65. Global CAR-T Cell Therapy Revenue (US$ Million) by Application (2026-2031)
Table 66. Global CAR-T Cell Therapy Revenue Market Share by Application (2020-2025)
Table 67. Global CAR-T Cell Therapy Revenue Market Share by Application (2026-2031)
Table 68. Global CAR-T Cell Therapy Price (US$/Unit) by Application (2020-2025)
Table 69. Global CAR-T Cell Therapy Price (US$/Unit) by Application (2026-2031)
Table 70. Bristol Myers Squibb Company Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Bristol Myers Squibb CAR-T Cell Therapy Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. Gilead Sciences Company Information
Table 76. Gilead Sciences Description and Business Overview
Table 77. Gilead Sciences CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Gilead Sciences CAR-T Cell Therapy Product
Table 79. Gilead Sciences Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Novartis CAR-T Cell Therapy Product
Table 84. Novartis Recent Developments/Updates
Table 85. Autolus Company Information
Table 86. Autolus Description and Business Overview
Table 87. Autolus CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Autolus CAR-T Cell Therapy Product
Table 89. Autolus Recent Developments/Updates
Table 90. Janssen Company Information
Table 91. Janssen Description and Business Overview
Table 92. Janssen CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Janssen CAR-T Cell Therapy Product
Table 94. Janssen Recent Developments/Updates
Table 95. JW Therapeutics Company Information
Table 96. JW Therapeutics Description and Business Overview
Table 97. JW Therapeutics CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. JW Therapeutics CAR-T Cell Therapy Product
Table 99. JW Therapeutics Recent Developments/Updates
Table 100. Beijing Immunochina Medical Science & Technology Company Information
Table 101. Beijing Immunochina Medical Science & Technology Description and Business Overview
Table 102. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Product
Table 104. Beijing Immunochina Medical Science & Technology Recent Developments/Updates
Table 105. Bioray Laboratories Company Information
Table 106. Bioray Laboratories Description and Business Overview
Table 107. Bioray Laboratories CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Bioray Laboratories CAR-T Cell Therapy Product
Table 109. Bioray Laboratories Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. CAR-T Cell Therapy Distributors List
Table 113. CAR-T Cell Therapy Customers List
Table 114. CAR-T Cell Therapy Market Trends
Table 115. CAR-T Cell Therapy Market Drivers
Table 116. CAR-T Cell Therapy Market Challenges
Table 117. CAR-T Cell Therapy Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of CAR-T Cell Therapy
Figure 2. Global CAR-T Cell Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CAR-T Cell Therapy Market Share by Type: 2024 & 2031
Figure 4. CD19 Product Picture
Figure 5. BCMA Product Picture
Figure 6. CD19/CD22 Product Picture
Figure 7. Other Product Picture
Figure 8. Global CAR-T Cell Therapy Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global CAR-T Cell Therapy Market Share by Application: 2024 & 2031
Figure 10. Non-hodgkin Lymphoma
Figure 11. Multiple Myeloma
Figure 12. Acute Lymphoblastic Leukemia
Figure 13. Other
Figure 14. Global CAR-T Cell Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global CAR-T Cell Therapy Market Size (2020-2031) & (US$ Million)
Figure 16. Global CAR-T Cell Therapy Sales (2020-2031) & (K Units)
Figure 17. Global CAR-T Cell Therapy Average Price (US$/Unit) & (2020-2031)
Figure 18. CAR-T Cell Therapy Report Years Considered
Figure 19. CAR-T Cell Therapy Sales Share by Manufacturers in 2024
Figure 20. Global CAR-T Cell Therapy Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest CAR-T Cell Therapy Players: Market Share by Revenue in CAR-T Cell Therapy in 2024
Figure 22. CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global CAR-T Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America CAR-T Cell Therapy Sales Market Share by Country (2020-2031)
Figure 25. North America CAR-T Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 26. United States CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe CAR-T Cell Therapy Sales Market Share by Country (2020-2031)
Figure 29. Europe CAR-T Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 30. Germany CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific CAR-T Cell Therapy Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific CAR-T Cell Therapy Revenue Market Share by Region (2020-2031)
Figure 37. China CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America CAR-T Cell Therapy Sales Market Share by Country (2020-2031)
Figure 45. Latin America CAR-T Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 46. Mexico CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa CAR-T Cell Therapy Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa CAR-T Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 51. Turkey CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of CAR-T Cell Therapy by Type (2020-2031)
Figure 55. Global Revenue Market Share of CAR-T Cell Therapy by Type (2020-2031)
Figure 56. Global CAR-T Cell Therapy Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of CAR-T Cell Therapy by Application (2020-2031)
Figure 58. Global Revenue Market Share of CAR-T Cell Therapy by Application (2020-2031)
Figure 59. Global CAR-T Cell Therapy Price (US$/Unit) by Application (2020-2031)
Figure 60. CAR-T Cell Therapy Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global CAR-T Cell Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global CAR-T Cell Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global CAR-T Cell Therapy Market Competitive Situation by Manufacturers in 2024
Table 4. Global CAR-T Cell Therapy Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global CAR-T Cell Therapy Sales Market Share by Manufacturers (2020-2025)
Table 6. Global CAR-T Cell Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global CAR-T Cell Therapy Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market CAR-T Cell Therapy Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of CAR-T Cell Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of CAR-T Cell Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CAR-T Cell Therapy, Product Type & Application
Table 12. Global Key Manufacturers of CAR-T Cell Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CAR-T Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Therapy as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CAR-T Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global CAR-T Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 18. Global CAR-T Cell Therapy Sales Market Share by Region (2020-2025)
Table 19. Global CAR-T Cell Therapy Sales by Region (2026-2031) & (K Units)
Table 20. Global CAR-T Cell Therapy Sales Market Share by Region (2026-2031)
Table 21. Global CAR-T Cell Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global CAR-T Cell Therapy Revenue Market Share by Region (2020-2025)
Table 23. Global CAR-T Cell Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global CAR-T Cell Therapy Revenue Market Share by Region (2026-2031)
Table 25. North America CAR-T Cell Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America CAR-T Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 27. North America CAR-T Cell Therapy Sales by Country (2026-2031) & (K Units)
Table 28. North America CAR-T Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America CAR-T Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe CAR-T Cell Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe CAR-T Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 32. Europe CAR-T Cell Therapy Sales by Country (2026-2031) & (K Units)
Table 33. Europe CAR-T Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe CAR-T Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific CAR-T Cell Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific CAR-T Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific CAR-T Cell Therapy Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific CAR-T Cell Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific CAR-T Cell Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America CAR-T Cell Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America CAR-T Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 42. Latin America CAR-T Cell Therapy Sales by Country (2026-2031) & (K Units)
Table 43. Latin America CAR-T Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America CAR-T Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa CAR-T Cell Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa CAR-T Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa CAR-T Cell Therapy Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa CAR-T Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa CAR-T Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global CAR-T Cell Therapy Sales (K Units) by Type (2020-2025)
Table 51. Global CAR-T Cell Therapy Sales (K Units) by Type (2026-2031)
Table 52. Global CAR-T Cell Therapy Sales Market Share by Type (2020-2025)
Table 53. Global CAR-T Cell Therapy Sales Market Share by Type (2026-2031)
Table 54. Global CAR-T Cell Therapy Revenue (US$ Million) by Type (2020-2025)
Table 55. Global CAR-T Cell Therapy Revenue (US$ Million) by Type (2026-2031)
Table 56. Global CAR-T Cell Therapy Revenue Market Share by Type (2020-2025)
Table 57. Global CAR-T Cell Therapy Revenue Market Share by Type (2026-2031)
Table 58. Global CAR-T Cell Therapy Price (US$/Unit) by Type (2020-2025)
Table 59. Global CAR-T Cell Therapy Price (US$/Unit) by Type (2026-2031)
Table 60. Global CAR-T Cell Therapy Sales (K Units) by Application (2020-2025)
Table 61. Global CAR-T Cell Therapy Sales (K Units) by Application (2026-2031)
Table 62. Global CAR-T Cell Therapy Sales Market Share by Application (2020-2025)
Table 63. Global CAR-T Cell Therapy Sales Market Share by Application (2026-2031)
Table 64. Global CAR-T Cell Therapy Revenue (US$ Million) by Application (2020-2025)
Table 65. Global CAR-T Cell Therapy Revenue (US$ Million) by Application (2026-2031)
Table 66. Global CAR-T Cell Therapy Revenue Market Share by Application (2020-2025)
Table 67. Global CAR-T Cell Therapy Revenue Market Share by Application (2026-2031)
Table 68. Global CAR-T Cell Therapy Price (US$/Unit) by Application (2020-2025)
Table 69. Global CAR-T Cell Therapy Price (US$/Unit) by Application (2026-2031)
Table 70. Bristol Myers Squibb Company Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Bristol Myers Squibb CAR-T Cell Therapy Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. Gilead Sciences Company Information
Table 76. Gilead Sciences Description and Business Overview
Table 77. Gilead Sciences CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Gilead Sciences CAR-T Cell Therapy Product
Table 79. Gilead Sciences Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Novartis CAR-T Cell Therapy Product
Table 84. Novartis Recent Developments/Updates
Table 85. Autolus Company Information
Table 86. Autolus Description and Business Overview
Table 87. Autolus CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Autolus CAR-T Cell Therapy Product
Table 89. Autolus Recent Developments/Updates
Table 90. Janssen Company Information
Table 91. Janssen Description and Business Overview
Table 92. Janssen CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Janssen CAR-T Cell Therapy Product
Table 94. Janssen Recent Developments/Updates
Table 95. JW Therapeutics Company Information
Table 96. JW Therapeutics Description and Business Overview
Table 97. JW Therapeutics CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. JW Therapeutics CAR-T Cell Therapy Product
Table 99. JW Therapeutics Recent Developments/Updates
Table 100. Beijing Immunochina Medical Science & Technology Company Information
Table 101. Beijing Immunochina Medical Science & Technology Description and Business Overview
Table 102. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Product
Table 104. Beijing Immunochina Medical Science & Technology Recent Developments/Updates
Table 105. Bioray Laboratories Company Information
Table 106. Bioray Laboratories Description and Business Overview
Table 107. Bioray Laboratories CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Bioray Laboratories CAR-T Cell Therapy Product
Table 109. Bioray Laboratories Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. CAR-T Cell Therapy Distributors List
Table 113. CAR-T Cell Therapy Customers List
Table 114. CAR-T Cell Therapy Market Trends
Table 115. CAR-T Cell Therapy Market Drivers
Table 116. CAR-T Cell Therapy Market Challenges
Table 117. CAR-T Cell Therapy Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of CAR-T Cell Therapy
Figure 2. Global CAR-T Cell Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CAR-T Cell Therapy Market Share by Type: 2024 & 2031
Figure 4. CD19 Product Picture
Figure 5. BCMA Product Picture
Figure 6. CD19/CD22 Product Picture
Figure 7. Other Product Picture
Figure 8. Global CAR-T Cell Therapy Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global CAR-T Cell Therapy Market Share by Application: 2024 & 2031
Figure 10. Non-hodgkin Lymphoma
Figure 11. Multiple Myeloma
Figure 12. Acute Lymphoblastic Leukemia
Figure 13. Other
Figure 14. Global CAR-T Cell Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global CAR-T Cell Therapy Market Size (2020-2031) & (US$ Million)
Figure 16. Global CAR-T Cell Therapy Sales (2020-2031) & (K Units)
Figure 17. Global CAR-T Cell Therapy Average Price (US$/Unit) & (2020-2031)
Figure 18. CAR-T Cell Therapy Report Years Considered
Figure 19. CAR-T Cell Therapy Sales Share by Manufacturers in 2024
Figure 20. Global CAR-T Cell Therapy Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest CAR-T Cell Therapy Players: Market Share by Revenue in CAR-T Cell Therapy in 2024
Figure 22. CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global CAR-T Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America CAR-T Cell Therapy Sales Market Share by Country (2020-2031)
Figure 25. North America CAR-T Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 26. United States CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe CAR-T Cell Therapy Sales Market Share by Country (2020-2031)
Figure 29. Europe CAR-T Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 30. Germany CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific CAR-T Cell Therapy Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific CAR-T Cell Therapy Revenue Market Share by Region (2020-2031)
Figure 37. China CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America CAR-T Cell Therapy Sales Market Share by Country (2020-2031)
Figure 45. Latin America CAR-T Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 46. Mexico CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa CAR-T Cell Therapy Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa CAR-T Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 51. Turkey CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE CAR-T Cell Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of CAR-T Cell Therapy by Type (2020-2031)
Figure 55. Global Revenue Market Share of CAR-T Cell Therapy by Type (2020-2031)
Figure 56. Global CAR-T Cell Therapy Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of CAR-T Cell Therapy by Application (2020-2031)
Figure 58. Global Revenue Market Share of CAR-T Cell Therapy by Application (2020-2031)
Figure 59. Global CAR-T Cell Therapy Price (US$/Unit) by Application (2020-2031)
Figure 60. CAR-T Cell Therapy Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232